![]() |
인쇄하기
취소
|
Hanmi Pharm announced an inflow of KRW 114.6 billion by the result of a series of technology exports.
According to the official notice, Hanmi Pharm unveiled the company received upfront payments of the total KRW 114.6 billion, KRW 54.8 billion and KRW 59.8 billion from Eli Lilly and Boehringer Ingelheim respectively, in the 3rd quarter.
Last March, Hanmi Pharm made the unprecedentedly largest...